Tag: Cooley
First ‘Six Little Dragons of Hangzhou’ goes public in HK
Manycore Tech is the first of the so-called “Six Little Dragons of Hangzhou” to go public and the world’s first listed spatial intelligence company after debuting on the HKEX on 17 April
The International A-list 2026
Bringing to the spotlight leading foreign lawyers that are the go-to advisers on India-related matters
Deals of the Year 2025
A look back at the blockbuster transactions of 2025 as we gallop into the Year of the Horse
Firms advise on GSK’s USD2.2bn RAPT buy, accesses China drug
British pharmaceutical giant GSK has entered an agreement to acquire US-based clinical-stage biopharmaceutical company RAPT Therapeutics for around USD2.2 billion
Cooley advises Jacobio’s USD2bn licensing deal with AstraZeneca
Cooley has advised Jacobio Pharmaceuticals on a record-breaking USD 2.02 billion global licensing agreement with AstraZeneca
The A-List 2025-26: Growth Drivers
Growth Drivers: We highlight leading Chinese and international lawyers who excel across legal and business sectors
Firms advise on Insilico Medicine’s HKD2.28bn HKEX IPO
AI drug discovery firm Insilico Medicine listed on the HKEX main board on 30 December 2025
Driverless firms Pony.ai, WeRide raise HKD9bn in HKEX IPOs
About 13 firms advised Guangzhou-based Pony.ai and WeRide on HKEX IPOs, raising HKD6.7b and HKD2.39b
Firms guide Seres on debut, HK’s largest carmaker IPO in 2025
Seres Group raised USD1.83bn in its HKEX debut, Hong Kong’s largest carmaker IPO and third-biggest listing of 2025, advised by Davis Polk, KWM, Cooley, Haiwen and Han Kun
Out-licensing is in
China's out-licensing boom: legal experts share tips for seamless pharma deals
Cooley shores up emerging companies, VC practice in Singapore
Cooley hires David He in Singapore to expand its venture capital practice
Firms act on Hengrui-GSK USD12.5bn drug development deal
Jiangsu Hengrui and GSK reached a USD12.5bn deal, with Cooley, Davis Polk and Han Kun advising
India rising, borders fading
As India expands its global trade ties and modernises its legal framework, international law firms are racing to keep pace
China Business Law Awards 2025
Which Chinese and international law firms have earned client trust through exceptional expertise?
Firms lead on Cerebrus minority investment in Aquatech
CAM, Cooley, S&R Associates, and Saul Ewing advised on Cerberus Capital’s minority investment in Aquatech International for an undisclosed amount
Shashwat Tewary moves to Cooley as partner in Singapore
Shashwat Tewary has joined Cooley’s Singapore office as a capital markets partner, bringing 16 years of regional experience
AZB, CAM and Cooley act on Reliance’s RISE esports JV
AZB, CAM, and Cooley advised on the RISE esports joint venture between Reliance’s RISE Worldwide and Denmark-based BLAST Esports
Cooley adds partner in Singapore amid Indian IPO push
Cooley has hired Shashwat Tewary from Sidley Austin as a partner in Singapore, boosting their Indian and Southeast Asian capital markets expertise
The International A-list 2025
We reveal the most-recommended foreign lawyers for India-related matters
Skadden Beijing to welcome new leadership, says source
After Sun Kai and Xu Yilin left Skadden's Beijing office, a source says partners will relocate from Hong Kong and Shanghai
Data privacy compliance in Singapore
Key legal considerations for Indian companies doing business in the city-state
Cooley grows capital markets with new partner in Beijing
Cooley has bolstered the talent at its Beijing office with the addition of capital markets partner Xu Yilin
ACC Singapore hosts sparkling year-end party
ACC Singapore hosted a "Sparkle and Cheer" year-end party on 5 December at PS Cafe
Proceed with caution
China's capital market faces tighter regulation, fewer new listings, and renewed interest in key international markets
China Business Law Awards 2024
China Business Law Journal reveals its top performing law firms of 2023
Rolling with the punches
The foreign firms that have overcome adversity and emerged as go-to choices for India legal matters
ACC Singapore’s first family day a hit
The Association of Corporate Counsel (ACC) Singapore held its first family day on 28 April at AT Feast in Dempsey
Investors ride wave of cross-border biomedical acquisitions
Amid the cool capital markets climate, the recent surge in billion-dollar M&A deals involving overseas biomedical companies
Legal luminaries celebrate at SCCA 21st annual black-tie event
Scores of legal luminaries helped the SCCA celebrate its 21st anniversary at the annual black-tie event
Six firms assist on AstraZeneca’s USD1.2bn Gracell purchase
Six firms act for parties involved with Anglo-Swedish pharmaceutical giant AstraZeneca’s acquisition of Chinese peer Gracell Biotechnologies for USD1.2 billion
Cooley, Davis Polk assist Chinese biopharma’s private placement
Cooley advises Gracell Biotechnologies, a Nasdaq-listed Chinese biopharmaceutical company, on its private placement financing of up to USD150 million
Cooley counsels Cholesgen on co-operation deal with AstraZeneca
Cooley assisted Cholesgen on its three-year co-operation contract with AstraZeneca, the British pharmaceutical giant, led by partner Christina Zhang
Five law firms advise on largest chapter 18A listing in Hong Kong
Five law firms advised on Chinese biotechnology company Laekna’s HKD791 million chapter 18A offering, which is the largest such IPO to date this year
China Business Law Awards 2023
China Business Law Journal reveals its top performing law firms of 2022
Cooley revamps leadership, refocuses practices
Cooley has revamped its Asian leadership, appointing its first partners in charge of the Hong Kong and Beijing offices, and resolving the succession of Christina Zhang, head of the Shanghai branch for more than a decade
Cooley restructures Asian leaderships, focuses on life sciences
Cooley has revamped its Asian leadership appointing its first partners in charge of the Hong Kong and Beijing offices, and resolved the succession of Christina Zhang, head of the Shanghai branch for more than a decade
Deals of the year 2022
India Business Law Journal reveals the standout deals and disputes of 2022 and the law firms that showed their worth in successfully concluding them
Structure Therapeutics raises USD180m in ADS offering
Biopharmaceutical company Structure Therapeutics raised USD134 million in a Nasdaq listing, offering 8.95 million American depositary shares (ADS) priced at USD15 each
Deals of the year 2022
China Business Law Journal announces the most exciting China-related legal transactions and disputes of 2022
Allen & Overy adds fund and asset management partner in Shanghai
Allen & Overy has strengthened its fund and asset management practice in the Asia-Pacific region with the hire of partner Daisy Qi to the Shanghai office
Former Morrison & Foerster partner joins Cooley’s Shanghai office
Cooley’s Shanghai office welcomed partner Li Ruomu to bolster the firm’s capabilities in mergers and acquisitions, private equity and venture capital transactions
China’s YishengBio eyes US capital markets via SPAC route
Yisheng Biopharma has abandoned its Hong Kong IPO and turned instead to the Nasdaq via the SPAC route in a deal that is expected to be sealed by the first quarter of 2023
HKEX gong chimes as GoGoX goes public
China’s third largest online logistics platform has debuted on the Hong Kong bourse – a move that summoned the strike of the gong back to the trading floor
China Business Law Awards 2022
China Business Law Journal reveals the law firms that have excelled in the past year
Deals of the Year
India Business Law Journal reveals the standout deals and disputes of 2021 and the law firms that worked hard to successfully conclude them

















































































